Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Cervical cytology reproducibility and associated clinical and demographic factors.

Hwang H, Follen M, Guillaud M, Scheurer M, MacAulay C, MacAulay C, Staerkel GA, van Niekerk D, Yamal JM.

Diagn Cytopathol. 2019 Oct 22. doi: 10.1002/dc.24325. [Epub ahead of print]

PMID:
31639288
2.

Confounders in Adenoma Detection at Initial Screening Colonoscopy: A Factor in the Assessment of Racial Disparities as a Risk for Colon Cancer.

David Y, Ottaviano L, Park J, Iqbal S, Likhtshteyn M, Kumar S, Lyo H, Lewis AE, Lung BE, Frye JT, Huang L, Li E, Yang J, Martello L, Vignesh S, Miller JD, Follen M, Grossman EB.

J Cancer Ther. 2019 Apr;10(4):269-289. doi: 10.4236/jct.2019.104022. Epub 2019 Apr 9.

3.

Blood biomarkers of expressed and inducible HIV-1.

Cillo AR, Hong F, Tsai A, Irrinki A, Kaur J, Sloan DD, Follen M, Geleziunas R, Cihlar T, Win SS, Murry JP, Mellors JW.

AIDS. 2018 Mar 27;32(6):699-708. doi: 10.1097/QAD.0000000000001748.

4.

Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.

Montealegre JR, Peckham-Gregory EC, Marquez-Do D, Dillon L, Guillaud M, Adler-Storthz K, Follen M, Scheurer ME.

Gynecol Oncol. 2018 Feb;148(2):357-362. doi: 10.1016/j.ygyno.2017.12.014. Epub 2017 Dec 21.

5.

Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes.

Montealegre JR, Varier I, Bracamontes CG, Dillon LM, Guillaud M, Sikora AG, Follen M, Adler-Storthz K, Scheurer ME.

Ethn Health. 2019 Oct;24(7):804-815. doi: 10.1080/13557858.2017.1373073. Epub 2017 Sep 4.

PMID:
28870103
6.

Fluorescence confocal endomicroscopy of the cervix: pilot study on the potential and limitations for clinical implementation.

Schlosser C, Bodenschatz N, Lam S, Lee M, McAlpine JN, Miller DM, Van Niekerk DJ, Follen M, Guillaud M, MacAulay CE, Lane PM.

J Biomed Opt. 2016 Dec 1;21(12):126011. doi: 10.1117/1.JBO.21.12.126011.

7.

Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer.

Nghiem VT, Davies KR, Beck JR, Follen M, Cantor SB.

Cancer Epidemiol Biomarkers Prev. 2016 May;25(5):807-14. doi: 10.1158/1055-9965.EPI-15-1044. Epub 2016 Feb 29.

8.

Prediction using hierarchical data: Applications for automated detection of cervical cancer.

Yamal JM, Guillaud M, Atkinson EN, Follen M, MacAulay C, Cantor SB, Cox DD.

Stat Anal Data Min. 2015 Apr;8(2):65-74. Epub 2015 Apr 8.

9.

Quantification of confocal fluorescence microscopy for the detection of cervical intraepithelial neoplasia.

Sheikhzadeh F, Ward RK, Carraro A, Chen ZY, van Niekerk D, Miller D, Ehlen T, MacAulay CE, Follen M, Lane PM, Guillaud M.

Biomed Eng Online. 2015 Oct 24;14:96. doi: 10.1186/s12938-015-0093-6.

10.

An alternative approach for estimating the accuracy of colposcopy in detecting cervical precancer.

Davies KR, Cantor SB, Cox DD, Follen M.

PLoS One. 2015 May 11;10(5):e0126573. doi: 10.1371/journal.pone.0126573. eCollection 2015.

11.

Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.

Nghiem VT, Davies KR, Beck JR, Follen M, MacAulay C, Guillaud M, Cantor SB.

Br J Cancer. 2015 Jun 9;112(12):1951-7. doi: 10.1038/bjc.2015.95. Epub 2015 Apr 28.

12.

Evaluation of HPV infection and smoking status impacts on cell proliferation in epithelial layers of cervical neoplasia.

Guillaud M, Buys TP, Carraro A, Korbelik J, Follen M, Scheurer M, Storthz KA, van Niekerk D, MacAulay CE.

PLoS One. 2014 Sep 11;9(9):e107088. doi: 10.1371/journal.pone.0107088. eCollection 2014.

13.

Association of traffic-related hazardous air pollutants and cervical dysplasia in an urban multiethnic population: a cross-sectional study.

Scheurer ME, Danysh HE, Follen M, Lupo PJ.

Environ Health. 2014 Jun 13;13(1):52. doi: 10.1186/1476-069X-13-52.

14.

Sociodemographic factors associated with pap test adherence and cervical dysplasia in surgically sterilized women.

Whitehouse KC, Montealegre JR, Follen M, Scheurer ME, Aagaard K.

J Reprod Infertil. 2014 Apr;15(2):94-104.

15.

A statistical model for removing inter-device differences in spectroscopy.

Wang L, Lee JS, Lane P, Atkinson EN, Zuluaga A, Follen M, MacAulay C, Cox DD.

Opt Express. 2014 Apr 7;22(7):7617-24. doi: 10.1364/OE.22.007617.

16.

Numerical investigation of two-dimensional light scattering patterns of cervical cell nuclei to map dysplastic changes at different epithelial depths.

Arifler D, Macaulay C, Follen M, Guillaud M.

Biomed Opt Express. 2014 Jan 15;5(2):485-98. doi: 10.1364/BOE.5.000485. eCollection 2014 Feb 1.

17.

Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens.

Li G, van Niekerk D, Miller D, Ehlen T, Garnis C, Follen M, Guillaud M, Macaulay C.

Exp Mol Pathol. 2014 Apr;96(2):168-77. doi: 10.1016/j.yexmp.2013.12.007. Epub 2014 Jan 8.

18.

Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings.

Luu HN, Adler-Storthz K, Dillon LM, Follen M, Scheurer ME.

Clin Med Insights Oncol. 2013 Sep 25;7:247-55. doi: 10.4137/CMO.S12811. eCollection 2013.

19.

Nativity disparities in late-stage diagnosis and cause-specific survival among Hispanic women with invasive cervical cancer: an analysis of Surveillance, Epidemiology, and End Results data.

Montealegre JR, Zhou R, Amirian ES, Follen M, Scheurer ME.

Cancer Causes Control. 2013 Nov;24(11):1985-94. doi: 10.1007/s10552-013-0274-1. Epub 2013 Aug 11.

20.

Ex vivo confocal imaging with contrast agents for the detection of oral potentially malignant lesions.

El Hallani S, Poh CF, Macaulay CE, Follen M, Guillaud M, Lane P.

Oral Oncol. 2013 Jun;49(6):582-90. doi: 10.1016/j.oraloncology.2013.01.009. Epub 2013 Feb 12.

22.

Nativity differences in behaviors associated with high-risk HPV infection among Hispanic women in Houston, Texas, USA.

Montealegre JR, Follen M, Scheurer ME.

J Immigr Minor Health. 2013 Aug;15(4):836-41. doi: 10.1007/s10903-012-9770-8.

23.

Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settings.

Yamal JM, Zewdie GA, Cox DD, Atkinson EN, Cantor SB, MacAulay C, Davies K, Adewole I, Buys TP, Follen M.

J Biomed Opt. 2012 Apr;17(4):047002. doi: 10.1117/1.JBO.17.4.047002.

24.

Drexel University and Drexel University College of Medicine: an overview of their commitment to women through education.

Price E, Follen M.

Gend Med. 2012 Feb;9(1 Suppl):S83-5. doi: 10.1016/j.genm.2011.11.005.

PMID:
22340644
25.
26.

Physician attitudes toward dissemination of optical spectroscopy devices for cervical cancer control: an industrial-academic collaborative study.

Shinn E, Qazi U, Gera S, Brodovsky J, Simpson J, Follen M, Basen-Engquist K, Macaulay C.

Gend Med. 2012 Feb;9(1 Suppl):S67-77; quiz 77.e1-6. doi: 10.1016/j.genm.2011.11.004.

27.

Promoting quality and safety in women's health through the use of transdisciplinary clinical simulation educational modules: methodology and a pilot trial.

Montgomery K, Morse C, Smith-Glasgow ME, Posmontier B, Follen M.

Gend Med. 2012 Feb;9(1 Suppl):S48-54. doi: 10.1016/j.genm.2011.11.001.

PMID:
22340640
28.

Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies.

Pham B, Rhodes H, Milbourne A, Adler-Storthz K, Follen M, Scheurer ME.

Gend Med. 2012 Feb;9(1 Suppl):S36-47. doi: 10.1016/j.genm.2011.10.006.

30.

The 2010 Annual Sex and Gender Research Forum at Drexel University and Drexel University College of Medicine: an institute for women's health and leadership initiative. Introduction.

Montgomery O, Follen M, Urdaneta-Hartmann S.

Gend Med. 2012 Feb;9(1 Suppl):S1-6. doi: 10.1016/j.genm.2011.08.004. No abstract available. Erratum in: Gend Med. 2012 Apr;9(2):137.

PMID:
22340637
31.

Optical technologies and molecular imaging for cervical neoplasia: a program project update.

Buys TP, Cantor SB, Guillaud M, Adler-Storthz K, Cox DD, Okolo C, Arulogon O, Oladepo O, Basen-Engquist K, Shinn E, Yamal JM, Beck JR, Scheurer ME, van Niekerk D, Malpica A, Matisic J, Staerkel G, Atkinson EN, Bidaut L, Lane P, Benedet JL, Miller D, Ehlen T, Price R, Adewole IF, MacAulay C, Follen M.

Gend Med. 2012 Feb;9(1 Suppl):S7-24. doi: 10.1016/j.genm.2011.08.002. Epub 2011 Sep 22.

32.

Classifying tissue samples from measurements on cells with within-class tissue sample heterogeneity.

Yamal JM, Follen M, Guillaud M, Cox DD.

Biostatistics. 2011 Oct;12(4):695-709. doi: 10.1093/biostatistics/kxr010. Epub 2011 Jun 3.

33.

Repeatability of tissue fluorescence measurements for the detection of cervical intraepithelial neoplasia.

Yamal JM, Cox DD, Atkinson EN, Macaulay C, Price R, Follen M.

Biomed Opt Express. 2010 Aug 19;1(2):641-657.

34.

Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria.

Okolo C, Franceschi S, Adewole I, Thomas JO, Follen M, Snijders PJ, Meijer CJ, Clifford GM.

Infect Agent Cancer. 2010 Dec 3;5(1):24. doi: 10.1186/1750-9378-5-24.

35.

Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia: Testing a device as an adjunct to colposcopy.

Cantor SB, Yamal JM, Guillaud M, Cox DD, Atkinson EN, Benedet JL, Miller D, Ehlen T, Matisic J, van Niekerk D, Bertrand M, Milbourne A, Rhodes H, Malpica A, Staerkel G, Nader-Eftekhari S, Adler-Storthz K, Scheurer ME, Basen-Engquist K, Shinn E, West LA, Vlastos AT, Tao X, Beck JR, Macaulay C, Follen M.

Int J Cancer. 2011 Mar 1;128(5):1151-68. doi: 10.1002/ijc.25667. Epub 2010 Nov 9.

36.

A health services research agenda for cellular, molecular and genomic technologies in cancer care.

Wideroff L, Phillips KA, Randhawa G, Ambs A, Armstrong K, Bennett CL, Brown ML, Donaldson MS, Follen M, Goldie SJ, Hiatt RA, Khoury MJ, Lewis G, McLeod HL, Piper M, Powell I, Schrag D, Schulman KA, Scott J.

Public Health Genomics. 2009;12(4):233-44. doi: 10.1159/000203779. Epub 2009 Feb 20. Review.

37.

Model-based analysis of reflectance and fluorescence spectra for in vivo detection of cervical dysplasia and cancer.

Redden Weber C, Schwarz RA, Atkinson EN, Cox DD, Macaulay C, Follen M, Richards-Kortum R.

J Biomed Opt. 2008 Nov-Dec;13(6):064016. doi: 10.1117/1.3013307.

38.

The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings.

Cárdenas-Turanzas M, Nogueras-Gonzalez GM, Scheurer ME, Adler-Storthz K, Benedet JL, Beck JR, Follen M, Cantor SB.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2865-71. doi: 10.1158/1055-9965.EPI-08-0137.

39.

The accuracy of the Papanicolaou smear in the screening and diagnostic settings.

Cárdenas-Turanzas M, Follen M, Nogueras-Gonzalez GM, Benedet JL, Beck JR, Cantor SB.

J Low Genit Tract Dis. 2008 Oct;12(4):269-75. doi: 10.1097/LGT.0b013e31816b44bc.

PMID:
18820540
40.

Communicating colposcopy results: what do patients and providers discuss?

Pruitt SL, Parker PA, Follen M, Basen-Engquist K.

J Low Genit Tract Dis. 2008 Apr;12(2):95-102. doi: 10.1097/LGT.0b013e31815a5142.

PMID:
18369302
41.

Automated image analysis of digital colposcopy for the detection of cervical neoplasia.

Park SY, Follen M, Milbourne A, Rhodes H, Malpica A, MacKinnon N, MacAulay C, Markey MK, Richards-Kortum R.

J Biomed Opt. 2008 Jan-Feb;13(1):014029. doi: 10.1117/1.2830654.

42.

Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia.

Shadeo A, Chari R, Lonergan KM, Pusic A, Miller D, Ehlen T, Van Niekerk D, Matisic J, Richards-Kortum R, Follen M, Guillaud M, Lam WL, MacAulay C.

BMC Genomics. 2008 Feb 4;9:64. doi: 10.1186/1471-2164-9-64.

43.

Accuracy of colposcopy in the diagnostic setting compared with the screening setting.

Cantor SB, Cárdenas-Turanzas M, Cox DD, Atkinson EN, Nogueras-Gonzalez GM, Beck JR, Follen M, Benedet JL.

Obstet Gynecol. 2008 Jan;111(1):7-14. doi: 10.1097/01.AOG.0000295870.67752.b4.

PMID:
18165387
44.

The clinical effectiveness of optical spectroscopy for the in vivo diagnosis of cervical intraepithelial neoplasia: where are we?

Cardenas-Turanzas M, Freeberg JA, Benedet JL, Atkinson EN, Cox DD, Richards-Kortum R, MacAulay C, Follen M, Cantor SB.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S138-46. Review.

PMID:
17908588
45.

Knowledge dissemination and evaluation in a cervical cancer screening implementation program in Nigeria.

Miller D, Okolo CA, Mirabal Y, Guillaud M, Arulogun OS, Oladepo O, Crain B, Follen M, Adewole IF.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S196-207. Epub 2007 Sep 21.

PMID:
17889285
46.

Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity.

Saldivar JS, Wu X, Follen M, Gershenson D.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S56-71. Epub 2007 Sep 19. Review.

PMID:
17884153
47.

A theory-aided dissemination strategy for emerging technologies in cervical cancer screening.

Shinn E, Basen-Engquist K, Crain B, Follen M.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S35-9. Epub 2007 Sep 17. No abstract available.

PMID:
17870151
48.

Multi-scale system biology applied to cervical inter-epithelial neoplasia.

Thiberville C, Guillaud M, Lockwood W, Lam W, Follen M, MacAulay C.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S72-82. Epub 2007 Sep 14. Review. No abstract available.

PMID:
17868784
49.

Inverse decision theory with applications to screening and diagnosis of cervical intraepithelial neoplasia.

Davies KR, Cox DD, Swartz RJ, Cantor SB, Follen M.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S187-95. Epub 2007 Sep 11.

PMID:
17850855
50.

p16 and MIB1 improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing.

Van Niekerk D, Guillaud M, Matisic J, Benedet JL, Freeberg JA, Follen M, MacAulay C.

Gynecol Oncol. 2007 Oct;107(1 Suppl 1):S233-40. Epub 2007 Sep 7.

PMID:
17825885

Supplemental Content

Loading ...
Support Center